Lieven Haenebalcke
Vlaams Instituut voor Biotechnologie(BE)Ghent University(BE)
Publications by Year
Research Areas
Pluripotent Stem Cells Research, CRISPR and Genetic Engineering, Animal Genetics and Reproduction, Angiogenesis and VEGF in Cancer, Acute Lymphoblastic Leukemia research
Most-Cited Works
- → Increased skeletal VEGF enhances β‐catenin activity and results in excessively ossified bones(2009)202 cited
- → Efficient mouse transgenesis using Gateway-compatible ROSA26 locus targeting vectors and F1 hybrid ES cells(2009)149 cited
- → p53 promotes VEGF expression and angiogenesis in the absence of an intact p21-Rb pathway(2013)119 cited
- → The EMT regulator Zeb2/Sip1 is essential for murine embryonic hematopoietic stem/progenitor cell differentiation and mobilization(2011)103 cited
- → ZEB2 drives immature T-cell lymphoblastic leukaemia development via enhanced tumour-initiating potential and IL-7 receptor signalling(2015)87 cited
- → The ROSA26-iPSC Mouse: A Conditional, Inducible, and Exchangeable Resource for Studying Cellular (De)Differentiation(2013)40 cited
- → Efficient ROSA26-Based Conditional and/or Inducible Transgenesis Using RMCE-Compatible F1 Hybrid Mouse Embryonic Stem Cells(2013)38 cited
- → p120 Catenin-Mediated Stabilization of E-Cadherin Is Essential for Primitive Endoderm Specification(2016)35 cited
- → Dual targeting of MAPK and PI3K pathways unlocks redifferentiation of Braf-mutated thyroid cancer organoids(2023)28 cited
- → Efficient and User-Friendly Pluripotin-based Derivation of Mouse Embryonic Stem Cells(2011)19 cited